| __timestamp | Ascendis Pharma A/S | Insmed Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 6274000 | 31073000 |
| Thursday, January 1, 2015 | 9415000 | 43216000 |
| Friday, January 1, 2016 | 11504000 | 50679000 |
| Sunday, January 1, 2017 | 13482000 | 79171000 |
| Monday, January 1, 2018 | 25057000 | 168218000 |
| Tuesday, January 1, 2019 | 48473000 | 210796000 |
| Wednesday, January 1, 2020 | 76669000 | 203613000 |
| Friday, January 1, 2021 | 160180000 | 234273000 |
| Saturday, January 1, 2022 | 221227000 | 265784000 |
| Sunday, January 1, 2023 | 264410000 | 344501000 |
| Monday, January 1, 2024 | 284545000 |
Unleashing insights
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. Over the past decade, Insmed Incorporated and Ascendis Pharma A/S have shown contrasting approaches to SG&A optimization. From 2014 to 2023, Insmed's SG&A expenses surged by over 1,000%, peaking at $344 million in 2023. In contrast, Ascendis Pharma's expenses grew by approximately 4,100%, reaching $264 million in the same year.
While both companies have seen significant increases, Ascendis Pharma's expenses grew at a faster rate, reflecting its aggressive expansion strategy. Insmed, however, maintained a steadier growth trajectory, suggesting a more controlled approach. This data highlights the strategic choices each company makes in balancing growth with cost management, offering valuable insights for investors and industry analysts alike.
Cost Management Insights: SG&A Expenses for Incyte Corporation and Ascendis Pharma A/S
Who Optimizes SG&A Costs Better? Summit Therapeutics Inc. or Insmed Incorporated
Who Optimizes SG&A Costs Better? Insmed Incorporated or Catalent, Inc.
Operational Costs Compared: SG&A Analysis of Insmed Incorporated and Dr. Reddy's Laboratories Limited
Selling, General, and Administrative Costs: Insmed Incorporated vs CymaBay Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Insmed Incorporated and MorphoSys AG
Comparing SG&A Expenses: Insmed Incorporated vs HUTCHMED (China) Limited Trends and Insights
Who Optimizes SG&A Costs Better? Insmed Incorporated or Wave Life Sciences Ltd.
Operational Costs Compared: SG&A Analysis of Insmed Incorporated and Evotec SE
Ascendis Pharma A/S and Lantheus Holdings, Inc.: SG&A Spending Patterns Compared
Ascendis Pharma A/S or Xenon Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Ascendis Pharma A/S or Galapagos NV